• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Gainers And Losers From June 11, 2024

    6/11/24 4:30:06 PM ET
    $CARA
    $CRBP
    $GNLN
    $GRWG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Heritage Cannabis Holding (OTC:HERTF) shares closed up 137.50% at $0.00
    • Elixinol Wellness (OTC:ELLXF) shares closed up 70.83% at $0.00
    • Affinor Growers (OTC:RSSFF) shares closed up 35.06% at $0.11
    • Rocky Mountain High (OTC:RMHB) shares closed up 27.27% at $0.01
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 14.68% at $50.31
    • CordovaCann (OTC:LVRLF) shares closed up 11.30% at $0.08
    • Psychemedics (NASDAQ:PMD) shares closed up 11.01% at $2.26
    • C21 Investments (OTC:CXXIF) shares closed up 10.09% at $0.30
    • Pharmadrug (OTC:LMLLF) shares closed up 9.58% at $0.02
    • Leafbuyer Techs (OTC:LBUY) shares closed up 8.46% at $0.03
    • 22nd Century Group (NASDAQ:XXII) shares closed up 6.17% at $0.73
    • Mexco Energy (AMEX:MXC) shares closed up 4.99% at $11.79
    • GrowGeneration (NASDAQ:GRWG) shares closed up 4.71% at $2.66
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 4.62% at $0.02

    LOSERS:

    • Global Compliance (OTC:FUAPF) shares closed down 18.95% at $0.01
    • 1933 Industries (OTC:TGIFF) shares closed down 15.79% at $0.01
    • EnWave (OTC:NWVCF) shares closed down 11.24% at $0.16
    • SOL Glb Inv (OTC:SOLCF) shares closed down 10.87% at $0.05
    • Cannabix Technologies (OTC:BLOZF) shares closed down 6.54% at $0.42
    • Cann Gr (OTC:CNGGF) shares closed down 5.66% at $0.05
    • Zelira Therapeutics (OTC:ZLDAF) shares closed down 5.64% at $0.29
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 4.71% at $0.66
    • CV Sciences (OTC:CVSI) shares closed down 4.67% at $0.09
    • Nextleaf Solutions (OTC:OILFF) shares closed down 4.53% at $0.08
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed down 4.30% at $0.49
    • Indiva (OTC:NDVAF) shares closed down 4.22% at $0.03

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRBP
    $GNLN
    $GRWG

    CompanyDatePrice TargetRatingAnalyst
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    12/2/2024Overweight
    Piper Sandler
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2024$85.00Outperform
    Wedbush
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/22/2024$80.00Buy
    H.C. Wainwright
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    6/26/2024$85.00Buy
    B. Riley Securities
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Decker Thomas H sold $70,375 worth of MXC COMMON STOCK (5,000 units at $14.07), decreasing direct ownership by 21% to 18,400 units (SEC Form 4)

    4 - MEXCO ENERGY CORP (0000066418) (Issuer)

    3/9/26 7:53:22 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 3 filed by new insider Hitchcock Jason

    3 - Greenlane Holdings, Inc. (0001743745) (Issuer)

    3/6/26 4:55:35 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Chief Medical Officer Smethurst Dominic sold $50,601 worth of shares (6,097 units at $8.30), decreasing direct ownership by 6% to 89,790 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    3/4/26 4:30:18 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    CEO Lampert Darren bought $98,340 worth of shares (82,639 units at $1.19), increasing direct ownership by 5% to 1,728,522 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:01 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Corbus Pharma with a new price target

    B. Riley Securities resumed coverage of Corbus Pharma with a rating of Buy and set a new price target of $28.00

    7/30/25 8:22:15 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Corbus Pharma

    William Blair initiated coverage of Corbus Pharma with a rating of Outperform

    2/28/25 7:22:12 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler initiated coverage on Corbus Pharma

    Piper Sandler initiated coverage of Corbus Pharma with a rating of Overweight

    12/2/24 9:55:40 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GNLN
    $GRWG
    SEC Filings

    View All

    SEC Form 10-K filed by Corbus Pharmaceuticals Holdings Inc.

    10-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    3/9/26 4:16:00 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    3/9/26 7:43:03 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Greenlane Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Greenlane Holdings, Inc. (0001743745) (Filer)

    3/4/26 4:12:48 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $CARA
    $CRBP
    $GNLN
    $GRWG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GrowGeneration Announces Fourth Quarter and Full Year 2025 Earnings Release Conference Call for March 19, 2026

    DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 21623. A recording of the webcast can be accesse

    3/5/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Greenlane Posts Investor Overview on Company Website

    BOCA RATON, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), today announced the posting of an investor overview document titled "Investor Overview: Greenlane Holdings and the Berachain Digital Asset Treasury Strategy" (the "Investor Overview") on the Company's website. The Investor Overview provides background on the Company's Berachain-focused digital asset treasury strategy, including the Company's publicly reported BERA holdings, staking activity, and validator deployment, as well as an overview of the Berachain ecosystem. All Company-specific data referenc

    3/3/26 9:23:53 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Greenlane Provides Digital Asset Treasury Update: Completes Deployment of Approximately 50 Million Units of BERA

    Total holdings of approximately 70.4 million units of BERA as of February 27, 2026 Up to 50 million units of BERA deployed into validator infrastructure across multiple operators Jason Hitchcock appointed Chief Executive Officer to advance DAT strategy BOCA RATON, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), is providing an update on its holdings of units of BERA and deployment activity. Digital Asset Treasury Holdings Update As of February 27, 2026, the Company held approximately 70.4 million units of BERA1. Since the Company's last treasury update on

    3/3/26 7:30:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Financials

    Live finance-specific insights

    View All

    GrowGeneration Announces Fourth Quarter and Full Year 2025 Earnings Release Conference Call for March 19, 2026

    DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 21623. A recording of the webcast can be accesse

    3/5/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Mexco Energy Corporation Reports Financial Results for Third Quarter

    MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

    2/10/26 5:00:00 PM ET
    $MXC
    Oil & Gas Production
    Energy

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Leadership Updates

    Live Leadership Updates

    View All

    Greenlane Provides Digital Asset Treasury Update: Completes Deployment of Approximately 50 Million Units of BERA

    Total holdings of approximately 70.4 million units of BERA as of February 27, 2026 Up to 50 million units of BERA deployed into validator infrastructure across multiple operators Jason Hitchcock appointed Chief Executive Officer to advance DAT strategy BOCA RATON, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), is providing an update on its holdings of units of BERA and deployment activity. Digital Asset Treasury Holdings Update As of February 27, 2026, the Company held approximately 70.4 million units of BERA1. Since the Company's last treasury update on

    3/3/26 7:30:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Greenlane Appoints Jason Hitchcock as Chief Executive Officer to Advance Digital Asset Treasury Strategy

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN) today announced the appointment of Jason Hitchcock as its Chief Executive Officer, effective immediately. Mr. Hitchcock is a technology executive with over 15 years of experience building and scaling revenue engines across SaaS, blockchain infrastructure, and decentralized finance. He joins Greenlane as the Company continues to execute its Berachain-focused Digital Asset Treasury ("DAT") strategy, combining disciplined capital allocation with active ecosystem participation through validator operations, staking, and liquidity provisioning. Technology Leadership and Ent

    2/18/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

    Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution. These initial Pinnacle VLN® shipments will support a sales launch expected on September 1, 2025 at almost 1,000 locations across 12 states for a

    8/4/25 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CRBP
    $GNLN
    $GRWG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/5/24 6:04:48 PM ET
    $PMD
    Medical Specialities
    Health Care